Pfizer to buy cancer biotech company Seagen for $43 billion
"Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients," said Pfizer Chairman and CEO Albert Bourla.
More from New York Business
Crain's New York Business
'Naked Gun' star Liam Neeson sells UWS apartment for $10.3M
New York Business
•
Aug 6, 2025
Crain's New York Business
Westchester and Long Island drive growth in New York's medical outpatient market
New York Business
•
Aug 6, 2025
Crain's New York Business
Teaneck hospital spends $10M to kick of multi-year development
New York Business
•
Aug 6, 2025
Crain's New York Business
Northwell's $2B Lenox Hill expansion heads for key vote
New York Business
•
Aug 6, 2025
Country Folks
Crop Comments: Should the Chicago Board of Trade Deal in Hay Futures?
New York Business
•
Aug 6, 2025
Crain's New York Business
Pfizer lifts profit view as cuts offset flat sales outlook
New York Business
•
Aug 6, 2025
Crain's New York Business
Vornado looks to sell Chicago and San Francisco office buildings, doubling down on New York
New York Business
•
Aug 5, 2025